sulfapyridine has been researched along with Bowel Diseases, Inflammatory in 7 studies
Sulfapyridine: Antibacterial, potentially toxic, used to treat certain skin diseases.
sulfapyridine : A sulfonamide consisting of pyridine with a 4-aminobenzenesulfonamido group at the 2-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "5%) had adverse effects that led to discontinuation of therapy in 14 (11." | 1.28 | Relationship between the acetylator phenotype, plasma sulfapyridine levels and adverse effects during treatment with salicylazosulfapyridine in patients with chronic bowel diseases. ( Levy, M; Rachmilewitz, D; Rahav, G; Zylber-Katz, E, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (85.71) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Joshi, R | 1 |
| Kumar, S | 1 |
| Unnikrishnan, M | 1 |
| Mukherjee, T | 1 |
| Bruin, KF | 1 |
| Hommes, DW | 1 |
| Jansen, J | 1 |
| Tytgat, GN | 1 |
| Wouter ten Cate, J | 1 |
| van Deventer, SJ | 1 |
| Sheldon, P | 1 |
| Pell, P | 1 |
| Giaffer, MH | 1 |
| O'Brien, CJ | 1 |
| Holdsworth, CD | 1 |
| Gaginella, TS | 1 |
| Walsh, RE | 1 |
| Mahida, YR | 1 |
| Lamming, CE | 1 |
| Gallagher, A | 1 |
| Hawthorne, AB | 1 |
| Hawkey, CJ | 1 |
| Rahav, G | 1 |
| Zylber-Katz, E | 1 |
| Rachmilewitz, D | 1 |
| Levy, M | 1 |
1 review available for sulfapyridine and Bowel Diseases, Inflammatory
| Article | Year |
|---|---|
Sulfasalazine. Multiplicity of action.
Topics: Aminosalicylic Acids; Animals; Free Radical Scavengers; Humans; Hydroxyeicosatetraenoic Acids; Infla | 1992 |
6 other studies available for sulfapyridine and Bowel Diseases, Inflammatory
| Article | Year |
|---|---|
Free radical scavenging reactions of sulfasalazine, 5-aminosalicylic acid and sulfapyridine: mechanistic aspects and antioxidant activity.
Topics: Aminosalicylic Acids; Anions; Antioxidants; Electrons; Free Radical Scavengers; Free Radicals; Gluta | 2005 |
Modulation of cytokine release from human monocytes by drugs used in the therapy of inflammatory bowel diseases.
Topics: Aminosalicylic Acids; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non | 1995 |
Comparison of the effects of sulphasalazine, 5-aminosalicylic acid and sulphapyridine on the humoral response to antigen in vivo.
Topics: Administration, Oral; Aminosalicylic Acids; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibo | 1995 |
Clinical tolerance to three 5-aminosalicylic acid releasing preparations in patients with inflammatory bowel disease intolerant or allergic to sulphasalazine.
Topics: Aminosalicylic Acids; Drug Hypersensitivity; Female; Humans; Inflammatory Bowel Diseases; Male; Mesa | 1992 |
5-Aminosalicylic acid is a potent inhibitor of interleukin 1 beta production in organ culture of colonic biopsy specimens from patients with inflammatory bowel disease.
Topics: Adult; Aged; Aged, 80 and over; Aminosalicylic Acids; Colitis, Ulcerative; Colon; Crohn Disease; Dex | 1991 |
Relationship between the acetylator phenotype, plasma sulfapyridine levels and adverse effects during treatment with salicylazosulfapyridine in patients with chronic bowel diseases.
Topics: Acetylation; Adolescent; Adult; Aged; Chronic Disease; Dose-Response Relationship, Drug; Female; Hum | 1990 |